Marimed (MRMD) Non Operating Investment Income (2012 - 2022)
Marimed's (MRMD) quarterly Non Operating Investment Income came in at $48000.0 in Q1 2022, up 206.67% year-on-year from $15652.2 in Q1 2021, and up 128.37% on a QoQ basis from -$169203.0 in Q4 2021.
Marimed (MRMD) Non Operating Investment Income (2012 - 2022) Analysis & Trends
Marimed (MRMD) has 8 years of Non Operating Investment Income data on file, last reported at $48000.0 in Q1 2022.
- On a quarterly basis, Non Operating Investment Income rose 206.67% year-over-year to $48000.0 in Q1 2022; TTM through Mar 2022 was -$1.0 million, a 446.63% decrease from a year earlier, with the FY2021 full-year figure at -$1.1 million, down 216.5% from the prior year.
- Non Operating Investment Income for Q1 2022 stood at $48000.0, up from -$169203.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for MRMD reached as high as $354534.0 in Q4 2020 and fell as low as -$687002.0 in Q1 2020.
- Historically, Non Operating Investment Income has averaged -$156451.8 across 3 years, with a median of -$169203.0 in 2021.
- Across the five-year window, Non Operating Investment Income slumped 340.19% in 2021 and surged 206.67% in 2022, its largest moves.
- Year by year, Non Operating Investment Income stood at $354534.0 in 2020, then plunged by 147.73% to -$169203.0 in 2021, then jumped by 128.37% to $48000.0 in 2022.
- Per Business Quant data, the three most recent Non Operating Investment Income figures were $48000.0 in Q1 2022, -$169203.0 in Q4 2021, and -$522106.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 48,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Dec 31, 2021 | -169,203.00 |
| Dec 31, 2021 | -169,203.00 |
| Sep 30, 2021 | -522,106.00 |
| Sep 30, 2021 | -522,106.00 |
| Jun 30, 2021 | -370,119.00 |
| Jun 30, 2021 | -370,119.00 |
| Mar 31, 2021 | -45,000.00 |
| Mar 31, 2021 | -45,000.00 |
| Dec 31, 2020 | 354,534.00 |
| Dec 31, 2020 | 354,534.00 |
| Sep 30, 2020 | 217,374.00 |
| Sep 30, 2020 | 217,374.00 |
| Jun 30, 2020 | -234,544.00 |
| Jun 30, 2020 | -234,544.00 |
| Mar 31, 2020 | -687,002.00 |
| Mar 31, 2020 | -687,002.00 |
| Dec 31, 2016 | -536.00 |
| Dec 31, 2016 | -536.00 |